Novartis Investigative Site

San José 95008

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Metastatic Breast Cancer

Studies at this site

• Roll-over Study to Allow Continued Access to Ribociclib — Running, not enrolling
• Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer — Completed